InvestorsHub Logo
Followers 5
Posts 82
Boards Moderated 0
Alias Born 05/04/2016

Re: None

Wednesday, 08/24/2016 12:06:49 AM

Wednesday, August 24, 2016 12:06:49 AM

Post# of 3063
$PTLF is employing a duel marketing strategy that consists of seeking FDA approval for one version of its therapy while marketing multiple additional versions as a nutraceuticals that do not require FDA approval. We believe this significantly reduces the Company’s overall risk profile. http://www.globesmallcap.com/scorpion-saves-pet-petlife-pharma-otcqbptlk/